HRP20161342T1 - Antimikrobni zavoj - Google Patents

Antimikrobni zavoj Download PDF

Info

Publication number
HRP20161342T1
HRP20161342T1 HRP20161342TT HRP20161342T HRP20161342T1 HR P20161342 T1 HRP20161342 T1 HR P20161342T1 HR P20161342T T HRP20161342T T HR P20161342TT HR P20161342 T HRP20161342 T HR P20161342T HR P20161342 T1 HRP20161342 T1 HR P20161342T1
Authority
HR
Croatia
Prior art keywords
bandage
pharmaceutically acceptable
acceptable salt
chlorhexidine
silver
Prior art date
Application number
HRP20161342TT
Other languages
English (en)
Inventor
Gianni Pecorari
Original Assignee
Emodial S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emodial S.R.L. filed Critical Emodial S.R.L.
Publication of HRP20161342T1 publication Critical patent/HRP20161342T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/206—Biguanides, e.g. chlorohexidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/624—Nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • A61M2025/0213—Holding devices, e.g. on the body where the catheter is attached by means specifically adapted to a part of the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • A61M2025/0266—Holding devices, e.g. on the body using pads, patches, tapes or the like
    • A61M2025/0273—Holding devices, e.g. on the body using pads, patches, tapes or the like having slits to place the pad around a catheter puncturing site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Claims (10)

1. Antimikrobni zavoj koji sadrži relativni dio (30) zavoja s antimikrobnim svojstvima koji ima relativnu površinu zavoja (110), te dio (30) zavoja sadrži: klorheksidin i/ili njegovu farmaceutski prihvatljivu sol u krutom stanju u relativnoj količini, izračunato kao ekvivalentna težina klorheksidin diglukonata/površina zavoja, u opsegu između 0.40 i 1.125 g/m2, i srebro i/ili njegovu farmaceutski prihvatljivu sol u krutom stanju u relativnoj količini, izračunato kao ekvivalentna težina metalnog srebra/površina zavoja većoj od ili jednakoj 0.1 mg/m2.
2. Zavoj prema prethodnom zahtjevu, naznačen time da je količina klorheksidina i/ili njegove farmaceutski prihvatljive soli u krutom stanju, izračunato kao ekvivalentna težina klorheksidin diglukonata/površina zavoja, veća od ili jednaka 0.425 mg/m2.
3. Zavoj prema bilo kojem od prethodnih zahtjeva, naznačen time da je količina srebra i/ili njegove farmaceutski prihvatljive soli u krutom stanju u relativnoj količini, izračunato kao ekvivalentna težina metalnog srebra/površina zavoja, veća od ili jednaka 0.2 mg/m2.
4. Zavoj prema bilo kojem od prethodnih zahtjeva, naznačen time da dio (30) zavoja ima omjer između njegove težine i površine zavoja koji je u opsegu između 100 i 150 g/m2, te sadrži: klorheksidin i/ili njegovu farmaceutski prihvatljivu sol u krutom stanju u relativnoj količini, izračunato kao ekvivalentna težina klorheksidin diglukonata/površina lijeka, u rasponu između 0.500 i 0.875 g/m2 i odgovara relativnom postotku, izračunato kao ekvivalentna težina klorheksidin diglukonata/ težina dijela zavoja (30) u postotcima, u rasponu između 0.40 i 0.70%; i srebro i/ili njegovu farmaceutski prihvatljivu sol u krutom stanju u relativnoj količini, izračunato kao ekvivalentna težina metalnog srebra/površina lijeka, u rasponu između 50 i 300 mg/m2 i odgovara relativnom postotku, izračunato kao ekvivalentna težina metalnog srebra/težina dijela zavoja u postotcima, koji se nalazi između 0.04% i 0.24%.
5. Zavoj prema bilo kojem od prethodnih zahtjeva, naznačen time da su kloroheksidin i/ili njegova farmaceutski prihvatljiva sol i/ili srebro i/ili njegova farmaceutski prihvatljiva sol u obliku nanočestica (2, 12).
6. Zavoj prema prethodnom zahtjevu, naznačen time da svaka pojedinačna nanočestica (2, 12) sadrži oba sastojka kloroheksidin i/ili njegovu farmaceutski prihvatljivu sol i srebro i/ili njegovu farmaceutski prihvatljivu sol.
7. Zavoj prema bilo kojem od prethodnih zahtjeva, naznačen time da dio (30) zavoja sadrži element metalnog srebra koji se bira iz skupine koju čine: mreža ili mrežica koja je izvedena korištenjem žica metalnog srebra i tankog perforiranog sloja metalnog srebra; te pri čemu su klorheksidin i/ili njegova farmaceutski prihvatljiva sol smješteni na metalni element.
8. Zavoj prema bilo kojem od prethodnih zahtjeva od 1 do 6, naznačen time da relativni dio (30) zavoja dodatno sadrži: površinski sloj (110) koji označava površinu zavoja za kontakt s kožom pacijenta, sloj je propustan za krv i tjelesni eksudat; i barem upijajući unutrašnji sloj (120) za upijanje krvi i tjelesnog eksudata; pri čemu barem jedan od površinskog sloja (110) i/ili unutrašnjeg upijajućeg sloja (120) sadrži klorheksidin i/ili njegovu farmaceutski prihvatljivu sol i srebro i/ili njegovu farmaceutski prihvatljivu sol.
9. Zavoj prema bilo kojem od prethodnih zahtjeva za zaštitu izlazne točke kod usađivanja katetera kod pacijenta, u kojem je relativni dio (30) zavoja prilagođen na takav način da okružuje kateter na dijelu gdje kateter izlazi iz tijela pacijenta kada se površina s lijekom (110) primjenjuje na kožu na mjestu izlaza kod presađivanja.
10. Zavoj prema prethodnom zahtjevu, naznačen time da relativni dio (30) zavoja je izveden sa prorezom (14) koji ima oblik i dimenzije koje su takve da se omogućava prolaz katetera koji je izvan tijela da prijeđe dio (30) zavoja i okružuje dio katetera kada se površina s lijekom (110) primjenjuje na kožu na mjestu izlaza kod presađivanja.
HRP20161342TT 2012-04-06 2016-10-13 Antimikrobni zavoj HRP20161342T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000185A ITBO20120185A1 (it) 2012-04-06 2012-04-06 Medicazione antimicrobica, composizione antimicrobica e relativo uso
EP13724402.6A EP2833929B1 (en) 2012-04-06 2013-04-04 Antimicrobial dressing
PCT/IB2013/052712 WO2013150487A1 (en) 2012-04-06 2013-04-04 An anti-microbial dressing, an anti-microbial composition and use thereof

Publications (1)

Publication Number Publication Date
HRP20161342T1 true HRP20161342T1 (hr) 2017-01-27

Family

ID=46208637

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20161342TT HRP20161342T1 (hr) 2012-04-06 2016-10-13 Antimikrobni zavoj

Country Status (14)

Country Link
US (1) US20150057617A1 (hr)
EP (1) EP2833929B1 (hr)
JP (1) JP6213851B2 (hr)
CN (1) CN104394896B (hr)
CA (1) CA2869367C (hr)
DK (1) DK2833929T3 (hr)
ES (1) ES2600735T3 (hr)
HR (1) HRP20161342T1 (hr)
IT (1) ITBO20120185A1 (hr)
PL (1) PL2833929T3 (hr)
PT (1) PT2833929T (hr)
RU (1) RU2014141515A (hr)
SI (1) SI2833929T1 (hr)
WO (1) WO2013150487A1 (hr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220232950A1 (en) * 2015-10-16 2022-07-28 Amolifescience Co., Ltd. Dry cosmetic sheet
GB201711181D0 (en) 2017-07-12 2017-08-23 Smith & Nephew Polymer foam material, device and use
GB201711183D0 (en) 2017-07-12 2017-08-23 Smith & Nephew Antimicrobial or wound care materials, devices and uses
GB201711179D0 (en) * 2017-07-12 2017-08-23 Smith & Nephew Wound care materials, devices and uses
US20220175585A1 (en) * 2019-04-01 2022-06-09 3M Innovative Properties Company Conformable dressing

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3774567D1 (de) * 1986-09-20 1991-12-19 Smith & Nephew Heftpflaster.
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
JPH0910296A (ja) * 1995-06-30 1997-01-14 Unitika Ltd 体液吸収用品
WO2008157092A1 (en) * 2007-06-20 2008-12-24 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
KR20100103834A (ko) * 2007-12-20 2010-09-28 아스트라제네카 아베 분말 ８５４를 탈응집하는 장치 및 방법
CN101224310B (zh) * 2008-01-18 2010-11-03 中国人民解放军第四军医大学 一种载有抗菌药物纳米微粒的医用创伤敷料
US20110038910A1 (en) * 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US10500173B2 (en) * 2010-06-17 2019-12-10 Covalon Technologies Inc. Antimicrobial silicone-based wound dressings
US20130267490A1 (en) * 2010-08-02 2013-10-10 Ranbaxy Laboratories Limited Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
CZ22394U1 (cs) * 2011-03-11 2011-06-20 Contipro C, A.S. Antimikrobiální smes a kryt pro podporu hojení ran s antimikrobiálním úcinkem

Also Published As

Publication number Publication date
US20150057617A1 (en) 2015-02-26
EP2833929B1 (en) 2016-07-27
JP2015523101A (ja) 2015-08-13
ES2600735T3 (es) 2017-02-10
RU2014141515A (ru) 2016-05-27
CN104394896B (zh) 2016-12-21
WO2013150487A1 (en) 2013-10-10
DK2833929T3 (en) 2016-10-10
ITBO20120185A1 (it) 2013-10-07
CN104394896A (zh) 2015-03-04
SI2833929T1 (sl) 2017-01-31
CA2869367C (en) 2021-04-27
JP6213851B2 (ja) 2017-10-18
CA2869367A1 (en) 2013-10-10
PT2833929T (pt) 2016-11-04
PL2833929T3 (pl) 2017-08-31
EP2833929A1 (en) 2015-02-11

Similar Documents

Publication Publication Date Title
HRP20161342T1 (hr) Antimikrobni zavoj
Krysiak et al. Electrospun fibers as carriers for topical drug delivery and release in skin bandages and patches for atopic dermatitis treatment
ES2369564T3 (es) Apósito.
ES2657216T3 (es) Apósito para la piel o para heridas para la cicatrización húmeda
Mirhaj et al. An overview on the recent advances in the treatment of infected wounds: Antibacterial wound dressings
EP2644114A3 (en) Layered tissue thickness compensator
FI3551238T3 (fi) Hajunpoistokoostumuksia, erityisesti yhdessä avannelaitteiden kanssa
US20100260824A1 (en) Antimicrobial Foam Compositions, Articles and Methods
DE602007013369D1 (de) Medizinische vorrichtungen mit einem porösen metalloxid- oder metallmaterial und einer polymerbeschichtung zur freisetzung von therapeutika
BRPI0621164B8 (pt) pó hesmostático, bandagem hesmostática para feridas e método de manufatura de um pó hesmostático
ATE498027T1 (de) Wirkstoffabgebende verbundkörper
ES2322218B1 (es) Compuestos antimicrobianos y apositos que los contienen.
Elsner et al. Highly porous drug-eluting structures: From wound dressings to stents and scaffolds for tissue regeneration
WO2012017349A3 (en) Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
NZ605469A (en) Nalbuphine-based formulations and uses thereof
AT413471B (de) Prophylaxeartikel
HRP20130123T1 (hr) Postupak lijeäśenja bolesti
RU2017141536A (ru) Замещенные производные индол-5-ола и их терапевтические применения
JP2024520383A (ja) 膣内リング器具
MX360002B (es) Formulaciones mejoradas para dispositivos médicos recubiertos con medicamento.
WO2016116403A8 (en) Polyurethaneurea solutions for compositions with active ingredients or fragrances
HRP20200971T1 (hr) Modulacija djelovanja epidermalnog faktora rasta koji veže heparin u svrhu zacijeljivanja membrane bubnjića
WO2009080321A3 (en) Lamellar shaped layers in medical devices
DE102007050668A1 (de) Stent mit einem Grundkörper aus einem bioinerten metallischen Implantatwerkstoff
HRP20201630T1 (hr) Sastavi i postupci za liječenje kožnog t-staničnog limfoma